Live
IlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - TradingViewIlluminaIllumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact - PR NewswireEndpoints NewsTrumpRx adds hundreds of generic medicines to siteClinical OMICsSmart Wristband Detects Cardiac Arrest with 92% Sensitivity in Early Clinical StudyEndpoints NewsAnother Paragon offshoot chooses reverse merger, this time for migraine drugs10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanksClinical OMICsADHD Brain Marker Value in DoubtEndpoints NewsAcceleron leaders and Westlake jumpstart new IPF biotechBio-RadAssessing Bio-Rad Laboratories (BIO) Valuation After Recent Share Price Rebound And ddPCR Growth Prospects - simplywall.stBioWorldSEC looks to reforms to Make IPOs Great AgainBioWorldDaewoong nabs Innovo’s preclinical IBD asset in ₩663B dealBioWorldLife sciences ‘sweet’ opportunity in US-China talks
Waters Feb 10, 2026

Waters Corporation (WAT): Guggenheim Reiterates 'Buy' Rating wit - GuruFocus

Waters Corporation (WAT): Guggenheim Reiterates 'Buy' Rating wit - GuruFocus

Original
Body unavailable. Use the original source.